What is NDC 42023-105?

42023-105 is the product NDC for Brevital Sodium (methohexital sodium), Methohexital sodium 500 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Par Health USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

What drug is associated with this NDC?

Brevital Sodium (Methohexital sodium).

Par Health USA, LLC, NDC labeler code 42023. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Brevital Sodium?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Brevital Sodium NDC 42023-105 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)42023-105Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42023-0105Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
42023-105-01	42023010501	1 VIAL in 1 CARTON (42023-105-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIALMarketed from Nov 1, 2007

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Brevital Sodium
Generic name (nonproprietary): methohexital sodium
Active ingredients: Methohexital sodium — 500 mg/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intramuscular, Intravenous, Rectal
Labeler: Par Health USA, LLCNDC labeler code 42023
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 011559
Marketing start: Nov 1, 2007
Listing expires: Dec 31, 2027
DEA schedule: CIV
Other FDA classes: Barbiturates (Chemical structure)
Identifiers: Product ID 42023-105_6efcbde7-9a3d-4d12-93ea-793a9e72725aSPL ID 6efcbde7-9a3d-4d12-93ea-793a9e72725aSPL set ID eccd8340-ead3-4363-8902-0c19d33aa2acRxCUI 1244233, 1244638UNII 60200PNZ7Q
Pharmacologic class: Barbiturate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N442023010501 followed by a unit qualifier and the quantity

Package 42023-0105-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 5, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE BREVITAL can be used in adults as follows: 1. For intravenous induction of anesthesia prior to the use of other general anesthetic agents. 2. For intravenous induction of anesthesia and as an adjunct to subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for short surgical procedures; BREVITAL may be given by infusion or intermittent injection. 3. For use along with other parenteral agents, usually narcotic analgesics, to supplement subpotent inhalational anesthetic agents (such as nitrous oxide in oxygen) for longer surgical procedures. 4. As intravenous anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 42023-105

What is NDC 42023-105?: 42023-105 is the product NDC for Brevital Sodium (methohexital sodium), Methohexital sodium 500 mg/1 injection, powder, lyophilized, for solution, listed with the FDA by Par Health USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Brevital Sodium (Methohexital sodium).
What is the active ingredient?: Methohexital sodium.
Who is the labeler?: Par Health USA, LLC, NDC labeler code 42023. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Brevital Sodium?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Brevital Sodium (Methohexital sodium) NDC 42023-105